Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool
Urologic Oncology: Seminars and Original Investigations | Mar 08, 2018
Conditional analyses of recurrence and progression in patients with TaG1 non-muscle-invasive bladder cancer
Urologic Oncology: Seminars and Original Investigations | Mar 08, 2018
Acetyl-CoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma
Urologic Oncology: Seminars and Original Investigations | Mar 07, 2018